Hormones and cancer.
Shang
Yongfeng
Y
Department of Biochemistry and Molecular Biology, Peking University Health Science Center, 38 Xueyuan Rd, Beijing 100083, China. yshang@hsc.pku.edu.cn
D002471:Cell Transformation, Neoplastic / Q000139:chemically induced / Q000473:pathology; D019175:DNA Methylation; D016889:Endometrial Neoplasms / Q000139:chemically induced / Q000378:metabolism* / Q000473:pathology; D004717:Endometrium / Q000187:drug effects / Q000378:metabolism / Q000473:pathology; D020847:Estrogen Receptor Modulators / Q000009:adverse effects / Q000494:pharmacology*; D047628:Estrogen Receptor alpha / Q000378:metabolism*; D004967:Estrogens / Q000009:adverse effects / Q000494:pharmacology*; D005260:Female; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D051762:PAX2 Transcription Factor / Q000819:agonists / Q000235:genetics / Q000378:metabolism*; D011401:Promoter Regions, Genetic; D020845:Selective Estrogen Receptor Modulators / Q000009:adverse effects / Q000494:pharmacology; D013629:Tamoxifen / Q000009:adverse effects / Q000494:pharmacology*
D020847:Estrogen Receptor Modulators; D047628:Estrogen Receptor alpha; D004967:Estrogens; D051762:PAX2 Transcription Factor; C497318:PAX2 protein, human; D020845:Selective Estrogen Receptor Modulators; D013629:Tamoxifen